首页 > 最新文献

Current obstetrics & gynaecology最新文献

英文 中文
Drugs in reproductive medicine 生殖医学中的药物
Pub Date : 2006-10-01 DOI: 10.1016/J.CUROBGYN.2006.07.002
Eleftherios Meridis, S. Lavery
{"title":"Drugs in reproductive medicine","authors":"Eleftherios Meridis, S. Lavery","doi":"10.1016/J.CUROBGYN.2006.07.002","DOIUrl":"https://doi.org/10.1016/J.CUROBGYN.2006.07.002","url":null,"abstract":"","PeriodicalId":84528,"journal":{"name":"Current obstetrics & gynaecology","volume":"17 1","pages":"281-288"},"PeriodicalIF":0.0,"publicationDate":"2006-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78388278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
MRCOG part II model essay answer MRCOG part II范文答案
Pub Date : 2006-10-01 DOI: 10.1016/j.curobgyn.2006.07.001
{"title":"MRCOG part II model essay answer","authors":"","doi":"10.1016/j.curobgyn.2006.07.001","DOIUrl":"https://doi.org/10.1016/j.curobgyn.2006.07.001","url":null,"abstract":"","PeriodicalId":84528,"journal":{"name":"Current obstetrics & gynaecology","volume":"16 5","pages":"Page 313"},"PeriodicalIF":0.0,"publicationDate":"2006-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.curobgyn.2006.07.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90129245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obesity complicating pregnancy 妊娠肥胖并发症
Pub Date : 2006-10-01 DOI: 10.1016/J.CUROBGYN.2006.07.005
R. Fraser
{"title":"Obesity complicating pregnancy","authors":"R. Fraser","doi":"10.1016/J.CUROBGYN.2006.07.005","DOIUrl":"https://doi.org/10.1016/J.CUROBGYN.2006.07.005","url":null,"abstract":"","PeriodicalId":84528,"journal":{"name":"Current obstetrics & gynaecology","volume":"92 1","pages":"295-298"},"PeriodicalIF":0.0,"publicationDate":"2006-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73685883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Drugs in reproductive medicine 生殖医学中的药物
Pub Date : 2006-10-01 DOI: 10.1016/j.curobgyn.2006.07.002
Eleftherios Meridis, Stuart Lavery

This article discusses some important and commonly used drugs in reproductive medicine, concentrating on the management of subfertility. Clomifene citrate is an effective first-line therapy in anovulation, resulting in 80% ovulation rates and 50–60% pregnancy rates. Gonadotrophins are effective ovulation-induction agents in cases of clomifene resistance or for superovulation protocols necessary for in vitro fertilisation. Metformin and aromatase inhibitors show promise, but further evidence is needed to support their routine use. Both gonadotrophin-releasing hormone agonists and antagonists are effective at preventing a premature surge of luteinising hormone, but it is unclear whether the antagonists, with their patient-friendly shorter cycle, will become the approach of choice. Concerns about the carcinogenic effects of infertility drugs do not seem to be supported by epidemiological evidence, but because of a possible time-lag effect, this area merits surveillance. Future developments include more patient-friendly drug-delivery systems.

本文讨论了生殖医学中一些重要和常用的药物,重点介绍了低生育能力的治疗。枸橼酸氯米芬是一种有效的无排卵一线治疗药物,可使排卵率达到80%,妊娠率达到50-60%。促性腺激素在克罗米芬耐药或体外受精所需的超排卵方案中是有效的促排卵剂。二甲双胍和芳香酶抑制剂显示出希望,但需要进一步的证据来支持它们的常规使用。促性腺激素释放激素激动剂和拮抗剂都能有效地预防促黄体生成素的过早激增,但目前尚不清楚拮抗剂是否会成为首选方法,因为它们对患者有利,周期更短。对不孕症药物致癌作用的担忧似乎没有流行病学证据支持,但由于可能存在时滞效应,这一领域值得监测。未来的发展包括更有利于患者的给药系统。
{"title":"Drugs in reproductive medicine","authors":"Eleftherios Meridis,&nbsp;Stuart Lavery","doi":"10.1016/j.curobgyn.2006.07.002","DOIUrl":"https://doi.org/10.1016/j.curobgyn.2006.07.002","url":null,"abstract":"<div><p>This article discusses some important and commonly used drugs in reproductive medicine, concentrating on the management of subfertility. Clomifene citrate is an effective first-line therapy in anovulation, resulting in 80% ovulation rates and 50–60% pregnancy rates. Gonadotrophins are effective ovulation-induction agents in cases of clomifene resistance or for superovulation protocols necessary for in vitro fertilisation. Metformin and aromatase inhibitors show promise, but further evidence is needed to support their routine use. Both gonadotrophin-releasing hormone agonists and antagonists are effective at preventing a premature surge of luteinising hormone, but it is unclear whether the antagonists, with their patient-friendly shorter cycle, will become the approach of choice. Concerns about the carcinogenic effects of infertility drugs do not seem to be supported by epidemiological evidence, but because of a possible time-lag effect, this area merits surveillance. Future developments include more patient-friendly drug-delivery systems.</p></div>","PeriodicalId":84528,"journal":{"name":"Current obstetrics & gynaecology","volume":"16 5","pages":"Pages 281-288"},"PeriodicalIF":0.0,"publicationDate":"2006-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.curobgyn.2006.07.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91768184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Fertility management of HIV couples 艾滋病毒夫妇的生育管理
Pub Date : 2006-10-01 DOI: 10.1016/j.curobgyn.2006.07.006
Carole Gilling-Smith

The development of highly active antiretroviral therapy has transformed the prognosis of patients infected with human immunodeficiency virus type 1 (HIV) living in the developed world and increased the demand for reproductive care for these patients. The primary aim is to ensure that infected individuals do not put their uninfected partner or unborn child at risk. Centres offering assisted-conception treatment to HIV couples need to provide risk-reduction options such as sperm-washing, and reproductive counselling, and ensure the safety of uninfected patients and healthcare workers in the centre. Where the man is HIV-1 positive and the women HIV-1 negative, sperm-washing is a well-established, effective means of reducing HIV transmission risk compared with timed, unprotected intercourse. If a couple have additional fertility issues, sperm-washing can be combined with ovulation induction, in vitro fertilization or intracytoplasmic sperm injection. In HIV-positive women trying to conceive, reducing risk lies primarily after conception in preventing mother-to-child transmission, achieved through the use of antiretroviral medication during pregnancy and delivery, caesarean or managed vaginal delivery and an avoidance of breast-feeding.

高效抗逆转录病毒疗法的发展改变了生活在发达国家的人类免疫缺陷病毒1型(艾滋病毒)感染者的预后,并增加了这些患者对生殖保健的需求。主要目的是确保受感染者不会使其未受感染的伴侣或未出生的孩子处于危险之中。向艾滋病毒夫妇提供辅助受孕治疗的中心需要提供减少风险的选择,如精子清洗和生殖咨询,并确保中心未感染患者和保健工作者的安全。在男性HIV-1阳性而女性HIV-1阴性的情况下,与定时、无保护的性交相比,洗精是一种公认的、有效的减少HIV传播风险的手段。如果一对夫妇有额外的生育问题,洗精可以结合促排卵、体外受精或卵浆内单精子注射。在试图怀孕的艾滋病毒阳性妇女中,减少风险主要在于怀孕后预防母婴传播,通过在怀孕和分娩期间使用抗逆转录病毒药物、剖腹产或经管理的阴道分娩以及避免母乳喂养来实现。
{"title":"Fertility management of HIV couples","authors":"Carole Gilling-Smith","doi":"10.1016/j.curobgyn.2006.07.006","DOIUrl":"10.1016/j.curobgyn.2006.07.006","url":null,"abstract":"<div><p>The development of highly active antiretroviral therapy has transformed the prognosis of patients infected with human immunodeficiency virus type 1 (HIV) living in the developed world and increased the demand for reproductive care for these patients. The primary aim is to ensure that infected individuals do not put their uninfected partner or unborn child at risk. Centres offering assisted-conception treatment to HIV couples need to provide risk-reduction options such as sperm-washing, and reproductive counselling, and ensure the safety of uninfected patients and healthcare workers in the centre. Where the man is HIV-1 positive and the women HIV-1 negative, sperm-washing is a well-established, effective means of reducing HIV transmission risk compared with timed, unprotected intercourse. If a couple have additional fertility issues, sperm-washing can be combined with ovulation induction, in vitro fertilization or intracytoplasmic sperm injection. In HIV-positive women trying to conceive, reducing risk lies primarily after conception in preventing mother-to-child transmission, achieved through the use of antiretroviral medication during pregnancy and delivery, caesarean or managed vaginal delivery and an avoidance of breast-feeding.</p></div>","PeriodicalId":84528,"journal":{"name":"Current obstetrics & gynaecology","volume":"16 5","pages":"Pages 299-305"},"PeriodicalIF":0.0,"publicationDate":"2006-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.curobgyn.2006.07.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73907645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Advances in fetal therapy 胎儿治疗进展
Pub Date : 2006-10-01 DOI: 10.1016/J.CUROBGYN.2006.06.001
S. China, M. Maaita, G. Bugg
{"title":"Advances in fetal therapy","authors":"S. China, M. Maaita, G. Bugg","doi":"10.1016/J.CUROBGYN.2006.06.001","DOIUrl":"https://doi.org/10.1016/J.CUROBGYN.2006.06.001","url":null,"abstract":"","PeriodicalId":84528,"journal":{"name":"Current obstetrics & gynaecology","volume":"26 1","pages":"255-260"},"PeriodicalIF":0.0,"publicationDate":"2006-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74321811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Self-assessment 自我评估
Pub Date : 2006-10-01 DOI: 10.1016/j.curobgyn.2006.07.008
{"title":"Self-assessment","authors":"","doi":"10.1016/j.curobgyn.2006.07.008","DOIUrl":"https://doi.org/10.1016/j.curobgyn.2006.07.008","url":null,"abstract":"","PeriodicalId":84528,"journal":{"name":"Current obstetrics & gynaecology","volume":"16 5","pages":"Pages 309-312"},"PeriodicalIF":0.0,"publicationDate":"2006-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.curobgyn.2006.07.008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90129244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prelim iv: Announcement 初稿四:公告
Pub Date : 2006-08-01 DOI: 10.1016/S0957-5847(06)00094-1
{"title":"Prelim iv: Announcement","authors":"","doi":"10.1016/S0957-5847(06)00094-1","DOIUrl":"https://doi.org/10.1016/S0957-5847(06)00094-1","url":null,"abstract":"","PeriodicalId":84528,"journal":{"name":"Current obstetrics & gynaecology","volume":"16 4","pages":"Page iv"},"PeriodicalIF":0.0,"publicationDate":"2006-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0957-5847(06)00094-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136476855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Malpresentations in labour 劳动中的不当表现
Pub Date : 2006-08-01 DOI: 10.1016/j.curobgyn.2006.05.007
Shipra Singh , Sara Paterson-Brown

Malpresentations of the fetus can arise by chance but can also be associated with maternal or foetal pathology. Excluding pathology is an important preliminary in their management, but even then they are associated with increased risks to both mother and fetus, including prolonged labour, cord prolapse, traumatic delivery and caesarean section. Early diagnosis and expert timely management are the cornerstones of good obstetric care generally, but they are crucial when malpresentations are first recognised in labour. The increasingly liberal use of caesarean section combined with the reduction in junior doctor working hours is decreasing clinical exposure and experience to these relatively rare obstetric complications. They will continue to occur, however, and therefore training to acquire and maintain skills in clinical assessment, decision making and obstetric manoeuvres is receiving increasing attention.

胎儿畸形可能是偶然出现的,但也可能与母体或胎儿的病理有关。排除病理是其治疗的重要基础,但即使如此,它们也与母亲和胎儿的风险增加有关,包括分娩时间延长、脐带脱垂、创伤性分娩和剖腹产。早期诊断和专家及时管理通常是良好产科护理的基石,但当在分娩中首次发现畸形时,它们至关重要。剖腹产手术的日益普及,加上初级医生工作时间的减少,减少了这些相对罕见的产科并发症的临床暴露和经验。但是,这种情况还会继续发生,因此,为获得和保持临床评估、决策和产科操作技能而进行的培训正日益受到重视。
{"title":"Malpresentations in labour","authors":"Shipra Singh ,&nbsp;Sara Paterson-Brown","doi":"10.1016/j.curobgyn.2006.05.007","DOIUrl":"https://doi.org/10.1016/j.curobgyn.2006.05.007","url":null,"abstract":"<div><p>Malpresentations of the fetus can arise by chance but can also be associated with maternal or foetal pathology. Excluding pathology is an important preliminary in their management, but even then they are associated with increased risks to both mother and fetus, including prolonged labour, cord prolapse, traumatic delivery and caesarean section. Early diagnosis and expert timely management are the cornerstones of good obstetric care generally, but they are crucial when malpresentations are first recognised in labour. The increasingly liberal use of caesarean section combined with the reduction in junior doctor working hours is decreasing clinical exposure and experience to these relatively rare obstetric complications. They will continue to occur, however, and therefore training to acquire and maintain skills in clinical assessment, decision making and obstetric manoeuvres is receiving increasing attention.</p></div>","PeriodicalId":84528,"journal":{"name":"Current obstetrics & gynaecology","volume":"16 4","pages":"Pages 234-241"},"PeriodicalIF":0.0,"publicationDate":"2006-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.curobgyn.2006.05.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136476856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dyspareunia in gynaecological practise 妇科实践中的性交困难
Pub Date : 2006-08-01 DOI: 10.1016/j.curobgyn.2006.05.006
Edward Morris, Sambit Mukhopadhyay

Dyspareunia is a form of sexual dysfunction that can significantly affect quality of life and cause relationship difficulties. It is a symptom of a variety of disease states with components of both physical and organic dysfunction. Obtaining a good sexual history in an outpatient setting requires high level of professionalism. A systematic examination of the lower genital tract is necessary to rule out any obvious cause, although further investigations such as ultrasound do not often offer additional information. Diagnostic laparoscopy is an invasive procedure that is of limited use in the management of dyspareunia but might help detect pelvic adhesions or endometriosis in those where this condition is suspected. Before embarking on a laparoscopy it is important for the patient to be aware of a management plan if the laparoscopy does not show any obvious cause. There are data to suggest that empirical medical treatment after clinical diagnosis of endometriosis is effective and has the advantage of avoiding any invasive procedures. Psychosexual causes are important to consider during the assessment of the patient experiencing dyspareunia.

性交困难是一种性功能障碍,会严重影响生活质量,并导致人际关系困难。它是多种疾病状态的症状,包括身体和器官功能障碍。在门诊环境中获得良好的性史需要很高的专业水平。系统检查下生殖道是必要的,以排除任何明显的原因,虽然进一步的调查,如超声往往不能提供额外的信息。诊断性腹腔镜检查是一种侵入性手术,在治疗性交困难方面应用有限,但可能有助于发现盆腔粘连或子宫内膜异位症。在进行腹腔镜检查之前,如果腹腔镜检查没有显示出任何明显的原因,对患者来说,了解治疗计划是很重要的。有资料表明,临床诊断子宫内膜异位症后的经验性治疗是有效的,并且具有避免任何侵入性手术的优点。在评估患者经历性交困难时,性心理原因是重要的。
{"title":"Dyspareunia in gynaecological practise","authors":"Edward Morris,&nbsp;Sambit Mukhopadhyay","doi":"10.1016/j.curobgyn.2006.05.006","DOIUrl":"https://doi.org/10.1016/j.curobgyn.2006.05.006","url":null,"abstract":"<div><p>Dyspareunia is a form of sexual dysfunction that can significantly affect quality of life and cause relationship difficulties. It is a symptom of a variety of disease states with components of both physical and organic dysfunction. Obtaining a good sexual history in an outpatient setting requires high level of professionalism. A systematic examination of the lower genital tract is necessary to rule out any obvious cause, although further investigations such as ultrasound do not often offer additional information. Diagnostic laparoscopy is an invasive procedure that is of limited use in the management of dyspareunia but might help detect pelvic adhesions or endometriosis in those where this condition is suspected. Before embarking on a laparoscopy it is important for the patient to be aware of a management plan if the laparoscopy does not show any obvious cause. There are data to suggest that empirical medical treatment after clinical diagnosis of endometriosis is effective and has the advantage of avoiding any invasive procedures. Psychosexual causes are important to consider during the assessment of the patient experiencing dyspareunia.</p></div>","PeriodicalId":84528,"journal":{"name":"Current obstetrics & gynaecology","volume":"16 4","pages":"Pages 226-233"},"PeriodicalIF":0.0,"publicationDate":"2006-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.curobgyn.2006.05.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136476852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current obstetrics & gynaecology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1